These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 32811221)

  • 21. Improved efficacy of low-dose spironolactone and metformin combination than either drug alone in the management of women with polycystic ovary syndrome (PCOS): a six-month, open-label randomized study.
    Ganie MA; Khurana ML; Nisar S; Shah PA; Shah ZA; Kulshrestha B; Gupta N; Zargar MA; Wani TA; Mudasir S; Mir FA; Taing S
    J Clin Endocrinol Metab; 2013 Sep; 98(9):3599-607. PubMed ID: 23846820
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effect of luteinizing hormone vs follicular stimulating hormone ratio on anti-Müllerian hormone secretion and folliculogenesis in patients with polycystic ovarian syndrome].
    Li Y; Wei LN; Xiong YL; Liang XY
    Zhonghua Fu Chan Ke Za Zhi; 2010 Aug; 45(8):567-70. PubMed ID: 21029609
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The plasminogen activator inhibitor-1 (PAI-1) gene -844 A/G and -675 4G/5G promoter polymorphism significantly influences plasma PAI-1 levels in women with polycystic ovary syndrome.
    Lin S; Huiya Z; Bo L; Wei W; Yongmei G
    Endocrine; 2009 Dec; 36(3):503-9. PubMed ID: 19856137
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effect of rosiglitazone on insulin resistance and hyperandrogenism in polycystic ovary syndrome].
    Zheng Z; Li M; Lin Y; Ma Y
    Zhonghua Fu Chan Ke Za Zhi; 2002 May; 37(5):271-3. PubMed ID: 12133398
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ovarian morphology as a predictor of hormonal values in polycystic ovary syndrome.
    van der Westhuizen S; van der Spuy ZM
    Ultrasound Obstet Gynecol; 1996 May; 7(5):335-41. PubMed ID: 8774098
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Selective effects of pioglitazone on insulin and androgen abnormalities in normo- and hyperinsulinaemic obese patients with polycystic ovary syndrome.
    Romualdi D; Guido M; Ciampelli M; Giuliani M; Leoni F; Perri C; Lanzone A
    Hum Reprod; 2003 Jun; 18(6):1210-8. PubMed ID: 12773448
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effect of abdominal acupuncture therapy on the endocrine and metabolism in obesity-type polycystic ovarian syndrome patients].
    Lai MH; Ma HX; Yao H; Liu H; Song XH; Huang WY; Wu XK
    Zhen Ci Yan Jiu; 2010 Aug; 35(4):298-302. PubMed ID: 21090334
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical and metabolic characteristics of Turkish adolescents with polycystic ovary syndrome.
    Ates S; Aydın S; Ozcan P; Soyman Z; Gokmen Karasu AF; Sevket O
    J Obstet Gynaecol; 2018 Feb; 38(2):236-240. PubMed ID: 28920502
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High-sensitivity C-reactive protein (hs-CRP) levels and its relationship with components of polycystic ovary syndrome in Indian adolescent women with polycystic ovary syndrome (PCOS).
    Ganie MA; Hassan S; Nisar S; Shamas N; Rashid A; Ahmed I; Douhat S; Mudassar S; Jan VM; Rashid F
    Gynecol Endocrinol; 2014 Nov; 30(11):781-4. PubMed ID: 25137507
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reproductive hormone metabolism in women with infertility due to polycystic ovary syndrome depending on the constitutional body types.
    Khmil M; Khmil S; Marushchak M; Halnykina S; Khmil A
    Pol Merkur Lekarski; 2020 Jun; 48(285):152. PubMed ID: 32564037
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical, metabolic, and endocrine parameters in response to metformin and lifestyle intervention in women with polycystic ovary syndrome: a randomized, double-blind, and placebo control trial.
    Fux Otta C; Wior M; Iraci GS; Kaplan R; Torres D; Gaido MI; Wyse EP
    Gynecol Endocrinol; 2010 Mar; 26(3):173-8. PubMed ID: 20148739
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of synbiotic pomegranate juice on glycemic, sex hormone profile and anthropometric indices in PCOS: A randomized, triple blind, controlled trial.
    Esmaeilinezhad Z; Babajafari S; Sohrabi Z; Eskandari MH; Amooee S; Barati-Boldaji R
    Nutr Metab Cardiovasc Dis; 2019 Feb; 29(2):201-208. PubMed ID: 30538082
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Effect of Berberine on Reproduction and Metabolism in Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis of Randomized Control Trials.
    Xie L; Zhang D; Ma H; He H; Xia Q; Shen W; Chang H; Deng Y; Wu Q; Cong J; Wang CC; Wu X
    Evid Based Complement Alternat Med; 2019; 2019():7918631. PubMed ID: 31915452
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of marjoram (Origanum majorana) tea on the hormonal profile of women with polycystic ovary syndrome: a randomised controlled pilot study.
    Haj-Husein I; Tukan S; Alkazaleh F
    J Hum Nutr Diet; 2016 Feb; 29(1):105-11. PubMed ID: 25662759
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effects of rosiglitazone and metformin on insulin resistance and serum androgen levels in obese and lean patients with polycystic ovary syndrome.
    Yilmaz M; Biri A; Karakoç A; Törüner F; Bingöl B; Cakir N; Tiras B; Ayvaz G; Arslan M
    J Endocrinol Invest; 2005 Dec; 28(11):1003-8. PubMed ID: 16483179
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Activity and distribution of plasma platelet-activating factor acetylhydrolase in polycystic ovary syndrome patients with insulin resistance].
    Wan DH; Fan P; Bai H; Song Q; Liu HW
    Zhonghua Fu Chan Ke Za Zhi; 2010 Jan; 45(1):30-4. PubMed ID: 20367923
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Liraglutide monotherapy and add on therapy on obese women with polycystic ovarian syndromes: a systematic review and meta-analysis.
    Tian D; Chen W; Xu Q; Li X; Lv Q
    Minerva Med; 2022 Jun; 113(3):542-550. PubMed ID: 33555153
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Associations between adipocyte fatty acid-binding protein and clinical parameters in polycystic ovary syndrome.
    Doğanay M; Ozyer SS; Var T; Tonguc E; Gun Eryilmaz O; Ozer I; Guzel AI
    Arch Gynecol Obstet; 2015 Feb; 291(2):447-50. PubMed ID: 25138125
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Predictive Role of Serum Cystatin C Levels in Polycystic Ovary Syndrome in Adolescents.
    Çınar M; Aksoy RT; Güzel Aİ; Tokmak A; Çandar T; Taşçı Y
    J Pediatr Adolesc Gynecol; 2016 Aug; 29(4):353-6. PubMed ID: 26740281
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [CORRELATION OF ANTI-MULLERIAN HORMONE WITH HORMONAL AND OVARIAN MORPHOLOGICAL CHARACTERISTICS IN PATIENTS WITH POLYCYSTIC OVARY SYNDROME WITH AND WITHOUT INSULIN RESISTANCE].
    Asanidze E; Khristesashvili J; Pkhaladze L; Barbakadze L
    Georgian Med News; 2018 Feb; (Issue):34-40. PubMed ID: 29578420
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.